The heart is not a pump alone.It is a coupled control system.
Cardiovascular care interprets pressure, flow, volume, electrical activation, myocardial function, valve mechanics, vascular anatomy and whole-person risk across seconds, years and decades. The decision unit is the current cardiovascular state, its trajectory, the threatened organ and the time available to act.
STATE
Cardiology begins where symptoms become physiologic states.
Cardiology and cardiovascular care include prevention, acute assessment, noninvasive testing, electrophysiology, interventional cardiology, structural heart care, cardiac surgery, heart-failure management, rehabilitation and lifelong risk modification. Symptoms such as chest discomfort, dyspnea, palpitations, syncope and edema are entry signals—not diagnoses.
Is tissue being perfused?
Coronary, systemic and pulmonary flow depend on pressure gradients, resistance, timing and vessel patency.
What load is imposed?
Preload, afterload, filling pressure and transvalvular gradients describe different forces.
Is activation effective?
Rate, origin, conduction, synchrony and duration determine electrical and mechanical consequences.
What happens under demand?
Resting measurements can miss ischemia, chronotropic limitation, valve symptoms and exercise intolerance.
A risk factor is not established disease. An abnormal ECG is not automatically acute ischemia. Elevated troponin indicates myocardial injury but does not by itself establish its mechanism. Reduced ejection fraction is one phenotype, not a complete description of heart failure. Each label must remain attached to method, timing, clinical context and uncertainty.
Every cardiac decision should be traceable to a signal.
Pressure is not flow. Ejection fraction is not cardiac output.
OUTPUT
Filling state
Volume, venous return and chamber compliance shape filling; congestion and effective perfusion can coexist.
Ejection resistance
Arterial impedance and outflow obstruction alter stroke work and measured ventricular performance.
Intrinsic pump performance
Contractile state cannot be inferred from one load-dependent measure alone.
Pressure–volume relationship
A stiff ventricle may generate high filling pressure despite preserved ejection fraction.
The right ventricle, pulmonary circulation, left heart and systemic vasculature operate in series. A change at one point redistributes pressure and flow throughout the circuit. Interpretation must integrate loading conditions, rhythm, ventilation, medication and measurement method.
Time matters—but classification must remain evidence-bound.
New or severe chest pressure, breathing difficulty, fainting, cold sweat, sudden weakness or rapidly worsening symptoms can represent an emergency. Local emergency services and patient-specific instructions take priority over any educational model.
A rhythm strip records activation. It does not automatically explain the patient.
Where does the impulse begin?
Sinus, atrial, junctional or ventricular origin changes mechanism and risk.
- P-wave relationship
- Onset and termination
- Trigger and substrate
How does it propagate?
AV conduction, bundle activation and accessory pathways shape intervals and morphology.
- PR and QRS
- Block level
- Rate dependence
What does the rhythm do?
The same rate can be tolerated or catastrophic depending on ventricle and context.
- Pressure and perfusion
- Ischemia and failure
- Loss of AV synchrony
What risk persists?
Atrial fibrillation requires stroke-risk and bleeding-risk reasoning beyond symptom control.
- Documented burden
- Risk factors
- Shared decision
Choose the test by the question—not by habit.
Heart failure is a syndrome with different mechanisms.
| Layer | Evidence | Question | Decision output | Common error |
|---|---|---|---|---|
| Clinical congestion | Dyspnea, orthopnea, edema, jugular venous pressure, weight and perfusion | Is the person wet, cold, both or neither? | Urgency and decongestion strategy | Edema assumed cardiac without differential |
| Ejection phenotype | LVEF with method, date, rhythm and loading state | Reduced, mildly reduced, preserved or improved? | Therapy framework and device eligibility context | One EF treated as immutable identity |
| Etiology | Ischemic, hypertensive, valvular, inflammatory, infiltrative, genetic or toxic evidence | What created the syndrome? | Disease-specific treatment | Congestion treated without cause |
| Hemodynamics | Pressure, output, resistance and response when needed | What limits flow or raises filling pressure? | Targeted optimization | Numbers interpreted outside conditions |
| Trajectory | Admissions, renal function, biomarkers, dose tolerance, function and frailty | Stable, improving, vulnerable or advanced? | Follow-up intensity and advanced-care referral | Discharge equals stability |
Severity, symptoms and ventricular consequence must converge.
When symptoms, physical examination and imaging disagree, do not average them into false certainty. Verify measurement quality, flow state, blood pressure, rhythm and lesion mechanism; then select the next test that resolves the decision.
Risk estimation starts a conversation. It does not replace clinical judgment.
Prevention before a clinical atherosclerotic event and prevention after established disease use different baseline risks and treatment thresholds. Family history, pregnancy history, kidney disease and other risk-enhancing contexts may materially alter interpretation.
A successful procedure must improve the right clinical endpoint.
Twelve presentations. Twelve different decision bottlenecks.
Dynamic symptoms with initially nondiagnostic ECG
- Control point
- Timing from symptom onset and assay-specific delta.
- Failure
- One normal ECG closes acute coronary evaluation.
Occlusion pattern with ongoing symptoms
- Control point
- System delay and contraindication-aware antithrombotic plan.
- Failure
- Administrative sequence outruns reperfusion clock.
Congestion with preserved ejection fraction
- Control point
- Filling pressure evidence and competing pulmonary/renal causes.
- Failure
- Preserved EF interpreted as absence of heart failure.
New atrial fibrillation with rapid ventricular response
- Control point
- Hemodynamic state, thromboembolic risk and reversible triggers.
- Failure
- Rate control considered complete disease management.
Transient loss of consciousness during exertion
- Control point
- Exertional context, injury, family history and structural disease.
- Failure
- Nonspecific normal tests converted into reassurance.
Discordant low-flow measurements
- Control point
- Gradient, area, stroke volume and loading conditions.
- Failure
- One cutoff decides intervention.
Unexplained hypertrophy with family implications
- Control point
- Phenocopies and variant classification.
- Failure
- Variant of uncertain significance used as predictive diagnosis.
Chest pain, troponin rise and nonobstructive coronaries
- Control point
- Clinical syndrome, arrhythmia and ventricular function.
- Failure
- Troponin elevation labeled infarction by default.
Hypotension with cold extremities and pulmonary edema
- Control point
- Rapidly distinguish pump, volume, distributive and obstructive states.
- Failure
- Pressure target pursued without restoring flow.
ICD alert and possible lead problem
- Control point
- True arrhythmia versus sensing, lead or programming issue.
- Failure
- Alert treated as diagnosis without stored evidence.
Cardiac disease under changing hemodynamic load
- Control point
- Pregnancy-compatible therapy and multidisciplinary ownership.
- Failure
- Standard regimen carried forward without reproductive safety review.
Declining function during cancer therapy
- Control point
- Preserve effective cancer therapy while preventing irreversible cardiac injury.
- Failure
- Cardiac and oncology decisions made in separate silos.
The discharge summary is a handoff—not an endpoint.
| Domain | Required state | Next decision | Closed-loop evidence | Failure mode |
|---|---|---|---|---|
| Medication | Indication, dose, contraindication, interaction and tolerance | Continue, titrate, switch or stop | Reconciled list and review date | Class prescribed without target or monitoring |
| Device / procedure | Implant/procedure, result, complication and restrictions | Interrogate, image, rehabilitate or reintervene | Named receiver and surveillance plan | Technical success without longitudinal owner |
| Rehabilitation | Functional baseline, exercise risk and barriers | Supervised progression and return goals | Attendance, capacity and symptom response | Referral issued but never completed |
| Risk factors | Blood pressure, lipids, glycemia, tobacco, kidney and weight context | Target and feasible intervention | Repeated measurement and adherence review | Advice without measurement loop |
| Symptoms | Expected course, red flags and escalation route | Routine review or urgent reassessment | Patient teach-back and access | Generic “return if worse” instruction |
Measure state transitions—not only procedures.
Forty connected healthcare knowledge nodes.
Cardiology and cardiovascular care, defined precisely.
Is every troponin elevation a heart attack?
No. Troponin above the applicable reference indicates myocardial injury. Myocardial infarction requires evidence of acute ischemia plus an acute injury pattern; many cardiac and noncardiac conditions can cause injury.
Does a normal ECG rule out acute coronary syndrome?
No. ECG sensitivity depends on timing, territory, lead selection and disease state. Serial ECGs, biomarkers and clinical assessment may be necessary.
Is ejection fraction the same as heart function?
No. EF is a load-dependent proportion of ventricular volume ejected per beat. It does not by itself describe filling pressure, output, valve function, right-heart performance or exercise reserve.
What is the difference between cardiac arrest and heart attack?
Cardiac arrest is loss of effective circulation, usually from an electrical or mechanical catastrophe. A heart attack is myocardial injury caused by acute ischemia; it can trigger cardiac arrest but the terms are not interchangeable.
Does atrial fibrillation always cause symptoms?
No. AF can be symptomatic, minimally symptomatic or silent. Decisions include rhythm or rate management, stroke prevention, trigger evaluation and treatment of associated disease.
Does severe valve disease always require immediate intervention?
No. Intervention depends on lesion, severity confidence, symptoms, ventricular response, anatomy, procedural risk, durability, goals and current guideline criteria.
What does cardiac rehabilitation include?
It is a structured program combining supervised activity, risk-factor management, medication support, education, psychosocial care and return-to-life planning after selected cardiovascular events or procedures.
Is this page medical advice?
No. It is a cardiovascular-system model. Individual symptoms, urgency, diagnosis, medication and procedural decisions require qualified local professionals.
Current physiology and guidelines before shortcuts.
Primary starting points include the American Heart Association guideline and statement library, the 2025 ACC/AHA acute coronary syndromes guideline hub, the European Society of Cardiology clinical practice guidelines, NHLBI heart testing resources, FDA cardiovascular-device resources and the AHA PREVENT risk tool. Application requires the current condition-specific guideline, device or drug labeling, validated measurement method and local emergency system.